Liver volumetry improves evaluation of treatment response to hepatic artery infusion chemotherapy in uveal melanoma patients with liver metastases

1. Rowcroft A, Loveday BPT, Thomson BNJ, Banting S, Knowles B. Systematic review of liver directed therapy for uveal melanoma hepatic metastases. HPB (Oxford) 2020; 22: 497–505. doi: 10.1016/j.hpb.2019.11.002 RowcroftA LovedayBPT ThomsonBNJ BantingS KnowlesB Systematic review of liver directed therapy for uveal melanoma hepatic metastases HPB (Oxford) 2020 22 497 505 10.1016/j.hpb.2019.11.002 Open DOISearch in Google Scholar

2. Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 2011; 118: 1881–5. doi: 10.1016/j.ophtha.2011.01.040 SinghAD TurellME TophamAK Uveal melanoma: trends in incidence, treatment, and survival Ophthalmology 2011 118 1881 5 10.1016/j.ophtha.2011.01.040 Open DOISearch in Google Scholar

3. Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB. Variates of survival in metastatic uveal melanoma. J Clin Oncol 2005; 23: 8076–80. doi: 10.1200/JCO.2005.02.6534 RietschelP PanageasKS HanlonC PatelA AbramsonDH ChapmanPB Variates of survival in metastatic uveal melanoma J Clin Oncol 2005 23 8076 80 10.1200/JCO.2005.02.6534 Open DOISearch in Google Scholar

4. Damato BE, Coupland SE. Differences in uveal melanomas between men and women from the British Isles. Eye 2012; 26: 292–9. doi: 10.1038/eye.2011.272 DamatoBE CouplandSE Differences in uveal melanomas between men and women from the British Isles Eye 2012 26 292 9 10.1038/eye.2011.272 Open DOISearch in Google Scholar

5. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Development of metastatic disease after enrolment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol 2005; 123: 1639–43. doi: 10.1001/archopht.123.12.1639 Diener-WestM ReynoldsSM AgugliaroDJ CaldwellR CummingK EarleJD Development of metastatic disease after enrolment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26 Arch Ophthalmol 2005 123 1639 43 10.1001/archopht.123.12.1639 Open DOISearch in Google Scholar

6. Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, et al. Survival of patents with metastases from uveal melanoma. Ophthalmology 1991; 98: 383–90. doi: 10.1016/s0161-6420(91)32285-1 GragoudasES EganKM SeddonJM GlynnRJ WalshSM FinnSM Survival of patents with metastases from uveal melanoma Ophthalmology 1991 98 383 90 10.1016/s0161-6420(91)32285-1 Open DOISearch in Google Scholar

7. Chew AL, Spilsbury K, Isaacs TW. Survival from uveal melanoma in Western Australia 1981–2005. Clin Exp Ophthalmol 2015; 43: 422–8. doi: 10.1111/ceo.12490 ChewAL SpilsburyK IsaacsTW Survival from uveal melanoma in Western Australia 1981–2005 Clin Exp Ophthalmol 2015 43 422 8 10.1111/ceo.12490 Open DOISearch in Google Scholar

8. Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, et al. Treatment of uveal melanoma metastatic to the liver. A review of the M. D. Anderson cancer center experience and prognostic factors. Cancer 1995; 76: 1665–70. doi: 10.1002/1097-0142(19951101)76:9<1665::aidcncr2820760925>3.0.co;2-j BedikianAY LeghaSS MavligitG CarrascoCH KhoranaS PlagerC Treatment of uveal melanoma metastatic to the liver. A review of the M. D. Anderson cancer center experience and prognostic factors Cancer 1995 76 1665 70 10.1002/1097-0142(19951101)76:9<1665::aidcncr2820760925>3.0.co;2-j Open DOISearch in Google Scholar

9. Schelhorn J, Richly H, Ruhlmann M, Lauenstein TC, Theysohn JM. A single-center experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma. Acta Radiol Open 2015; 4: 2047981615570417. doi: 10.1177/2047981615570417 SchelhornJ RichlyH RuhlmannM LauensteinTC TheysohnJM A single-center experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma Acta Radiol Open 2015 4 2047981615570417 10.1177/2047981615570417 Open DOISearch in Google Scholar

10. Heusner TA, Antoch G, Wittkowski-Sterczewski A, Ladd SC, Forsting M, Verhagen R, et al. Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment. RoFo 2011; 183: 1151–60. doi: 10.1055/s-0031-1281743 HeusnerTA AntochG Wittkowski-SterczewskiA LaddSC ForstingM VerhagenR Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment RoFo 2011 183 1151 60 10.1055/s-0031-1281743 Open DOISearch in Google Scholar

11. Leyvraz S, Piperno-Neumann S, Suciu S, Baurain JF, Zdzienicki M, Testori A, et al. Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial. Ann Oncol 2014; 25: 742–6. doi: 10.1093/annonc/mdt585 LeyvrazS Piperno-NeumannS SuciuS BaurainJF ZdzienickiM TestoriA Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial Ann Oncol 2014 25 742 6 10.1093/annonc/mdt585 Open DOISearch in Google Scholar

12. Duran R, Chapiro J, Frangakis C, Lin M, Schlachter TR, Schernthaner RE, et al. Uveal melanoma metastatic to the liver: the role of quantitative volumetric contrast-enhanced MR imaging in the assessment of early tumor response after transarterial chemoembolization. Transl Oncol 2014; 7: 447–55. doi: 10.1016/j.tranon.2014.05.004 DuranR ChapiroJ FrangakisC LinM SchlachterTR SchernthanerRE Uveal melanoma metastatic to the liver: the role of quantitative volumetric contrast-enhanced MR imaging in the assessment of early tumor response after transarterial chemoembolization Transl Oncol 2014 7 447 55 10.1016/j.tranon.2014.05.004 Open DOISearch in Google Scholar

13. Erasmus JJ, Gladish GW, Broemeling L, Sabloff BS, Truong MT, Herbst RS, et al. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol 2003; 21: 2574–82. doi: 10.1200/JCO.2003.01.144 ErasmusJJ GladishGW BroemelingL SabloffBS TruongMT HerbstRS Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response J Clin Oncol 2003 21 2574 82 10.1200/JCO.2003.01.144 Open DOISearch in Google Scholar

14. Thiesse P, Ollivier L, Di Stefano-Louineau D, Négrier S, Savary J, Pignard K, et al. Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d’Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 1997; 15: 3507–14. doi: 10.1200/JCO.1997.15.12.3507 ThiesseP OllivierL Di Stefano-LouineauD NégrierS SavaryJ PignardK Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d’Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer J Clin Oncol 1997 15 3507 14 10.1200/JCO.1997.15.12.3507 Open DOISearch in Google Scholar

15. Koitka S, Gudlin P, Theysohn JM, Oezcelik A, Hoyer DP, Dayangac M, et al. Fully automated preoperative liver volumetry incorporating the anatomical location of the central hepatic vein. Sci Rep 2022; 12: 16479. doi: 10.1038/s41598-022-20778-4 KoitkaS GudlinP TheysohnJM OezcelikA HoyerDP DayangacM Fully automated preoperative liver volumetry incorporating the anatomical location of the central hepatic vein Sci Rep 2022 12 16479 10.1038/s41598-022-20778-4 Open DOISearch in Google Scholar

16. Zensen S, Opitz MK, Ludwig JM, Haubold J, Richly H, Siveke JT, et al. Radiation dose aspects of hepatic artery infusion chemotherapy in uveal melanoma patients with liver metastases. Cardiovasc Intervent Radiol 2022; 45: 841–5. doi: 10.1007/s00270-022-03130-1 ZensenS OpitzMK LudwigJM HauboldJ RichlyH SivekeJT Radiation dose aspects of hepatic artery infusion chemotherapy in uveal melanoma patients with liver metastases Cardiovasc Intervent Radiol 2022 45 841 5 10.1007/s00270-022-03130-1 Open DOISearch in Google Scholar

17. Pinguet F, Culine S, Bressolle F, Astre C, Serre MP, Chevillard C, et al. A phase I and pharmacokinetic study of melphalan using a 24-hour continuous infusion in patients with advanced malignancies. Clin Cancer Res 2000; 6: 57–63. PMID: 10656432 PinguetF CulineS BressolleF AstreC SerreMP ChevillardC A phase I and pharmacokinetic study of melphalan using a 24-hour continuous infusion in patients with advanced malignancies Clin Cancer Res 2000 6 57 63 10656432 Search in Google Scholar

18. Boone BA, Perkins S, Bandi R, Santos E, McCluskey K, Bartlett DL, et al. Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma. J Surg Oncol 2018; 117: 940–6. doi: 10.1002/jso.24984 BooneBA PerkinsS BandiR SantosE McCluskeyK BartlettDL Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma J Surg Oncol 2018 117 940 6 10.1002/jso.24984 Open DOISearch in Google Scholar

19. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228–47. doi: 10.1016/j.ejca.2008.10.026 EisenhauerEA TherasseP BogaertsJ SchwartzLH SargentD FordR New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 2009 45 228 47 10.1016/j.ejca.2008.10.026 Open DOISearch in Google Scholar

20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–74. PMID: 843571 LandisJR KochGG The measurement of observer agreement for categorical data Biometrics 1977 33 159 74 843571 Search in Google Scholar

21. Karydis I, Gangi A, Wheater MJ, Choi J, Wilson I, Thomas K, et al. Percutaneous hepatic perfusion with melphalan in uveal melanoma: a safe and effective treatment modality in an orphan disease. J Surg Oncol 2018; 117: 1170–8. doi: 10.1002/jso.24956 KarydisI GangiA WheaterMJ ChoiJ WilsonI ThomasK Percutaneous hepatic perfusion with melphalan in uveal melanoma: a safe and effective treatment modality in an orphan disease J Surg Oncol 2018 117 1170 8 10.1002/jso.24956 Open DOISearch in Google Scholar

22. Kalkmann J, Forsting M, Stattaus J. Liver volume variations as a parameter to assess therapy response in advanced metastatic liver disease. Onkologie 2011; 34: 30–4. doi: 10.1159/000323373 KalkmannJ ForstingM StattausJ Liver volume variations as a parameter to assess therapy response in advanced metastatic liver disease Onkologie 2011 34 30 4 10.1159/000323373 Open DOISearch in Google Scholar

23. Purkiss SF, Williams NS. Growth rate and percentage hepatic replacement of colorectal liver metastases. Br J Surg 1993; 80: 1036–8. doi: 10.1002/bjs.1800800838 PurkissSF WilliamsNS Growth rate and percentage hepatic replacement of colorectal liver metastases Br J Surg 1993 80 1036 8 10.1002/bjs.1800800838 Open DOISearch in Google Scholar

24. Opitz M, Zensen S, Ludwig JM, Weber M, Alatzides G, Seifert R, et al. Radiation dose aspects and establishment of diagnostic reference levels for90Y radioembolisation during angiographic procedure. J Radiol Prot 2022; 42(3). doi: 10.1088/1361-6498/ac8f9e OpitzM ZensenS LudwigJM WeberM AlatzidesG SeifertR Radiation dose aspects and establishment of diagnostic reference levels for90Y radioembolisation during angiographic procedure J Radiol Prot 2022 42 3 10.1088/1361-6498/ac8f9e Open DOISearch in Google Scholar

25. Schaarschmidt BM, Wildgruber M, Kloeckner R, Nie J, Steinle V, Braat AJAT, et al. 90Y Radioembolization in the treatment of neuroendocrine neoplasms: results of an international multicenter retrospective study. J Nucl Med 2022; 63: 679–85. doi: 10.2967/jnumed.121.262561 SchaarschmidtBM WildgruberM KloecknerR NieJ SteinleV BraatAJAT 90Y Radioembolization in the treatment of neuroendocrine neoplasms: results of an international multicenter retrospective study J Nucl Med 2022 63 679 85 10.2967/jnumed.121.262561 Open DOISearch in Google Scholar

26. Schaarschmidt BM, Kloeckner R, Dertnig T, Demircioglu A, Müller L, Auer TA, et al. Real-life experience in the treatment of intrahepatic cholangiocarcinoma by 90Y radioembolization: a multicenter retrospective study. J Nucl Med 2023; 64: 529–35. doi: 10.2967/jnumed.122.264598 SchaarschmidtBM KloecknerR DertnigT DemirciogluA MüllerL AuerTA Real-life experience in the treatment of intrahepatic cholangiocarcinoma by 90Y radioembolization: a multicenter retrospective study J Nucl Med 2023 64 529 35 10.2967/jnumed.122.264598 Open DOISearch in Google Scholar

27. Krasovitsky M, Lee YC, Sim H-W, Chawla T, Moore H, Moses D, et al. Interobserver and intraobserver variability of RECIST assessment in ovarian cancer. Int J Gynecol Cancer 2022; 32: 656–61. doi: 10.1136/ijgc-2021-003319 KrasovitskyM LeeYC SimH-W ChawlaT MooreH MosesD Interobserver and intraobserver variability of RECIST assessment in ovarian cancer Int J Gynecol Cancer 2022 32 656 61 10.1136/ijgc-2021-003319 Open DOISearch in Google Scholar

28. Suzuki C, Torkzad MR, Jacobsson H, Aström G, Sundin A, Hatschek T, et al. Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria. Acta Oncol 2010; 49: 509–14. doi: 10.3109/02841861003705794 SuzukiC TorkzadMR JacobssonH AströmG SundinA HatschekT Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria Acta Oncol 2010 49 509 14 10.3109/02841861003705794 Open DOISearch in Google Scholar

29. Kuhl CK, Alparslan Y, Schmoee J, Sequeira B, Keulers A, Brümmendorf TH, et al. Validity of RECIST Version 1.1 for response assessment in metastatic cancer: a prospective, multireader study. Radiology 2019; 290: 349–56. doi: 10.1148/radiol.2018180648 KuhlCK AlparslanY SchmoeeJ SequeiraB KeulersA BrümmendorfTH Validity of RECIST Version 1.1 for response assessment in metastatic cancer: a prospective, multireader study Radiology 2019 290 349 56 10.1148/radiol.2018180648 Open DOISearch in Google Scholar

30. Gafita A, Rauscher I, Fendler WP, Murthy V, Hui W, Armstrong WR, et al. Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria. Eur J Nucl Med Mol Imaging 2022; 49: 4271–81. doi: 10.1007/s00259-022-05882-x GafitaA RauscherI FendlerWP MurthyV HuiW ArmstrongWR Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria Eur J Nucl Med Mol Imaging 2022 49 4271 81 10.1007/s00259-022-05882-x Open DOISearch in Google Scholar

31. Hagen F, Mair A, Bitzer M, Bösmüller H, Horger M. Fully automated whole-liver volume quantification on CT-image data: comparison with manual volumetry using enhanced and unenhanced images as well as two different radiation dose levels and two reconstruction kernels. PloS one 2021; 16: e0255374. doi: 10.1371/journal.pone.0255374 HagenF MairA BitzerM BösmüllerH HorgerM Fully automated whole-liver volume quantification on CT-image data: comparison with manual volumetry using enhanced and unenhanced images as well as two different radiation dose levels and two reconstruction kernels PloS one 2021 16 e0255374 10.1371/journal.pone.0255374 Open DOISearch in Google Scholar

32. Cai W, He B, Fan Y, Fang C, Jia F. Comparison of liver volumetry on contrast-enhanced CT images: one semiautomatic and two automatic approaches. J Appl Clin Med Phys 2016; 17: 118–27. doi: 10.1120/jacmp.v17i6.6485 CaiW HeB FanY FangC JiaF Comparison of liver volumetry on contrast-enhanced CT images: one semiautomatic and two automatic approaches J Appl Clin Med Phys 2016 17 118 27 10.1120/jacmp.v17i6.6485 Open DOISearch in Google Scholar

33. Suzuki K, Epstein ML, Kohlbrenner R, Garg S, Hori M, Oto A, et al. Quantitative radiology: automated CT liver volumetry compared with interactive volumetry and manual volumetry. AJR Am J Roentgenol 2011; 197: W706–12. doi: 10.2214/AJR.10.5958 SuzukiK EpsteinML KohlbrennerR GargS HoriM OtoA Quantitative radiology: automated CT liver volumetry compared with interactive volumetry and manual volumetry AJR Am J Roentgenol 2011 197 W706 12 10.2214/AJR.10.5958 Open DOISearch in Google Scholar